Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

RYAN vs CRVL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRVL Captures Overall Composite Edge (42.6 HOLD vs 40.7 SELL), While RYAN Leads 5–0 on Growth & Valuation Pillars

CRVL Overall Winner 6-Pillar Tally: RYAN 5 – 0 CRVL (1 Tie) Matrix Metrics: RYAN 3 – 7 CRVL

As of Nov 16, 2026, Corvel Corp (CRVL) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (42.6/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 7–3 (led by composite factor balance), while RYAN wins 5–0 across the 6-pillar growth and valuation breakdown. RYAN trades at $47.86 (19.7x Forward P/E, 19.8% operating margin) versus CRVL at $87.34 (23.8x Forward P/E, 15.9% operating margin).

  • Growth vs. Quality Trade-Off: CRVL earns the overall head-to-head edge with a stronger Unified Composite Score (42.6/100 HOLD vs. RYAN 40.7/100 SELL) and -0.17β · 33% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RYAN vs CRVL
RYAN NYSE
Ryan Specialty Holdings, Inc.
Insurance Agents, Brokers & Service
$47.86
+2.07% 1D
Market Cap $11.9B
TTM Revenue $6.20B
Forward P/E 19.7x
Beta / 30D Vol -0.32β · 39% Vol
Unified Composite Score
40.7 / 100 SELL
Tech 22.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 67
RSI-14: 66.9 · SMA20: $45.34 · SMA50: $41.30
CRVL NASDAQ Head-to-Head Winner
Corvel Corp
Insurance Agents, Brokers & Service
$87.34
+1.93% 1D
Market Cap $4.3B
TTM Revenue $1.01B
Forward P/E 23.8x
Beta / 30D Vol -0.17β · 33% Vol
Unified Composite Score
42.6 / 100 HOLD
Tech 42.0 Fund 40.0 Flow 50.0 Mom 25.9
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.9% over 20 days), RSI 66
RSI-14: 65.7 · SMA20: $83.74 · SMA50: $78.01

6-Pillar Scorecard Institutional Category Breakdown (RYAN 5 – 0 CRVL)

Columns: Metric · RYAN · CRVL
1. Valuation Multiples RYAN
Forward P/E 19.7x 23.8x
Trailing P/E 58.6x 36.0x
PEG Ratio N/M N/M
EV / Revenue 1.9x 4.3x
2. Growth & Scale RYAN
Revenue Growth (YoY) +4.8% +11.5%
Earnings Growth (YoY) +43.1% +24.1%
TTM Revenue (USD) $6.20B $1.01B
Market Cap $11.9B $4.3B
3. Profitability & Quality RYAN
Gross Margin 41.1% 25.5%
Operating Margin 19.8% 15.9%
Net Profit Margin 3.3% 12.0%
Return on Equity (ROE) 25.1% 30.6%
4. Balance Sheet & Cash Flow RYAN
Cash Generation (TTM) $1.77B EBITDA $195M EBITDA
Cash Flow Margin 28.5% EBITDA Mgn 19.3% EBITDA Mgn
Net Cash / Leverage $3.71 Book/Sh · 25.1% ROE $8.54 Book/Sh · 30.6% ROE
Dividend Yield 1.11% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 29.7% (12th %ile) 187.6% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat RYAN
OpEx & R&D Intensity 21.3% of Rev ($1.32B) 9.6% of Rev ($97M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RYAN (3) vs CRVL (7)
Institutional Metric RYAN CRVL Criterion Row Edge
Market Capitalization
Scale
$11.9B $4.3B Larger Scale RYAN
Trailing P/E Ratio
Valuation
58.6x 36.0x Lower Multiple CRVL
Forward P/E Ratio
Valuation
19.7x 23.8x Lower Multiple RYAN
Revenue Growth (YoY)
Growth
+4.8% +11.5% Higher Growth CRVL
Operating Margin (TTM)
Profitability
19.8% 15.9% Higher Margin RYAN
Net Profit Margin
Profitability
3.3% 12.0% Higher Margin CRVL
Return on Equity (ROE)
Capital Efficiency
25.1% 30.6% Higher ROE CRVL
52-Week Range Position
Momentum
63% ($29–$59) 95% ($45–$90) Stronger Trend CRVL
Beta / 30D Volatility
Risk Regime
-0.32β · 39% Vol -0.17β · 33% Vol Lower Realized Risk CRVL
Unified Institutional Score
Composite Signal
40.7 / 100 (SELL) 42.6 / 100 (HOLD) Higher Composite CRVL
Trailing 12M Revenue (USD)
Operating Scale
$6.20B $1.01B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
41.1% 25.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.9x EV/Rev N/M PEG · 4.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.77B EBITDA ($3.71 Book/Sh · 25.1% ROE) $195M EBITDA ($8.54 Book/Sh · 30.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon RYAN +7.85 pp
RYAN: +17.45% · CRVL: +9.6%
3M Horizon CRVL +13.65 pp
RYAN: +16.05% · CRVL: +29.7%
6M Horizon CRVL +5.62 pp
RYAN: +42.14% · CRVL: +47.76%
1Y Horizon CRVL +34.64 pp
RYAN: -15.83% · CRVL: +18.81%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RYAN vs CRVL. Trailing 12-month operating profitability (RYAN 19.8% vs CRVL 15.9%) and valuation multiples (RYAN 19.7x vs CRVL 23.8x Forward P/E) are benchmarked directly in Pillar 4 below.

RYAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.20B
Gross Margin41.1%
Op. Margin19.8%
ROE / Fwd P/E25.1% · 19.7x
CRVL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.01B
Gross Margin25.5%
Op. Margin15.9%
ROE / Fwd P/E30.6% · 23.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RYAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 29.7%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RYAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CRVL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 187.6%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRVL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RYAN Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $11.9B market capitalization and 19.8% operating margin.
OpEx & R&D Reinvestment 21.3% of Rev ($1.32B)
90D Engineering Disclosures 0 Published
CRVL Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 15.9% operating margin.
OpEx & R&D Reinvestment 9.6% of Rev ($97M)
90D Engineering Disclosures 0 Published

Investor FAQ RYAN vs CRVL Key Questions & Quantitative Answers

As of Nov 16, 2026, Corvel Corp (CRVL) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (42.6/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 7–3 (led by composite factor balance), while RYAN wins 5–0 across the 6-pillar growth and valuation breakdown. RYAN trades at $47.86 (19.7x Forward P/E, 19.8% operating margin) versus CRVL at $87.34 (23.8x Forward P/E, 15.9% operating margin). Growth vs. Quality Trade-Off: CRVL earns the overall head-to-head edge with a stronger Unified Composite Score (42.6/100 HOLD vs. RYAN 40.7/100 SELL) and -0.17β · 33% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

RYAN leads the Growth & Scale pillar: RYAN posts +4.8% YoY revenue growth and +43.1% YoY earnings growth on $6.20B TTM revenue (41.1% gross margin, 19.8% operating margin), compared with CRVL at +11.5% YoY revenue growth and +24.1% YoY earnings growth on $1.01B TTM revenue (25.5% gross margin, 15.9% operating margin). On trailing 12-month operating scale, RYAN generates $6.20B in USD-normalized revenue versus $1.01B for CRVL. In operating R&D and SG&A reinvestment, RYAN deploys 21.3% of Rev ($1.32B) (0 90-day corporate R&D disclosures) versus 9.6% of Rev ($97M) (0 disclosures) for CRVL.

RYAN screens cheaper on headline valuation multiples. RYAN trades at 19.7x Forward P/E, 58.6x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (28.5% EBITDA margin), whereas CRVL trades at 23.8x Forward P/E, 36.0x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (19.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RYAN (25.1% ROE) versus CRVL (30.6% ROE) capital efficiency.

In options market volatility and institutional positioning, RYAN carries 29.7% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.32β · 39% Vol realized risk). By comparison, CRVL carries 187.6% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.17β · 33% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.